PAPER Godoy JA, Rios JA, Zolezzi JM, Braidy N, Inestrosa NC
SEARCH RESULTS
331159 RESULTS
PAPER Atadzhanov M, Mwaba MH, Mukomena PN, Lakhi S, Mwaba P, Rayaprolu S, Meschia JF, Ross OA
Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population.
BMC Res Notes. 2014 Mar 28;7:194. PubMed: 24679048PAPER Wu MF, Yin JH, Hwang CS, Tang CM, Yang DI
NAD attenuates oxidative DNA damages induced by amyloid beta-peptide in primary rat cortical neurons.
Free Radic Res. 2014 Jul;48(7):794-805. Epub 2014 Apr 22 PubMed: 24678962PAPER Danborg PB, Simonsen AH, Waldemar G, Heegaard NH
The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.
Biomarkers. 2014 Jun;19(4):259-68. Epub 2014 Mar 29 PubMed: 24678935PAPER Wen-Zheng C, Gong L, Ying-Qiu X, Guo-Hua C, Kuo-Chen C
Apolipoprotein E Gene Variants of Alzheimer's Disease and Vascular Dementia Patients in a Community Population of Nanking.
Med Chem. 2014 Mar 27; PubMed: 24678786PAPER Burgold S, Filser S, Dorostkar MM, Schmidt B, Herms J
In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques.
Acta Neuropathol Commun. 2014 Mar 28;2(1):30. PubMed: 24678659PAPER Poulsen K, Bahl JM, Simonsen AH, Hasselbalch SG, Heegaard NH
Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer's disease and mild cognitive impairment.
Clin Proteomics. 2014 Mar 29;11(1):12. PubMed: 24678637PAPER Rist PM, Capistrant BD, Wu Q, Marden JR, Glymour MM
Dementia and dependence: do modifiable risk factors delay disability?
Neurology. 2014 Apr 29;82(17):1543-50. Epub 2014 Mar 28 PubMed: 24682970PAPER Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.
Neurology. 2014 Apr 29;82(17):1514-20. Epub 2014 Mar 28 PubMed: 24682965PAPER Reddy PH
Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
Drug Discov Today. 2014 Jul;19(7):951-5. Epub 2014 Mar 28 PubMed: 24681059PAPER Hall JM, Shine JM, Walton CC, Gilat M, Kamsma YP, Naismith SL, Lewis SJ
Early phenotypic differences between Parkinson's disease patients with and without freezing of gait.
Parkinsonism Relat Disord. 2014 Jun;20(6):604-7. Epub 2014 Mar 12 PubMed: 24679901PAPER de Lau LM, Verbaan D, Marinus J, van Hilten JJ
Survival in Parkinson's disease. Relation with motor and non-motor features.
Parkinsonism Relat Disord. 2014 Jun;20(6):613-6. Epub 2014 Mar 12 PubMed: 24679900PAPER Katayama S, Imai R, Sugiyama H, Nakamura S
Oral administration of soy peptides suppresses cognitive decline by induction of neurotrophic factors in SAMP8 mice.
J Agric Food Chem. 2014 Apr 23;62(16):3563-9. Epub 2014 Apr 8 PubMed: 24678753PAPER Sollberger M, Rosen HJ, Shany-Ur T, Ullah J, Stanley CM, Laluz V, Weiner MW, Wilson SM, Miller BL, Rankin KP
Neural substrates of socioemotional self-awareness in neurodegenerative disease.
Brain Behav. 2014 Mar;4(2):201-14. Epub 2014 Jan 13 PubMed: 24683513PAPER Zeng L, Tallaksen-Greene SJ, Wang B, Albin RL, Paulson HL
The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.
J Huntingtons Dis. 2013 Jun 18;2(1):201-215. PubMed: 24683430Current Filters
No filters selected